Showing results (81-90 of 123) with videos related to
Sort By:
Pageof 13
British Journal of Rheumatology|May 6, 1998
Improvement of physical fitness and muscle strength in polymyositis/dermatomyositis patients by a training programmeG F Wiesinger, M Quittan, M Aringer, et al.Lupus|November 11, 2011
Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus reportM Aringer, H Burkhardt, G R Burmester, et al.Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[AV-block II and arthritis as manifestations of Lyme borreliosis]M Aringer, C Pirich, S Wenger, et al.Lupus|June 3, 2016
Multiparametric detection of autoantibodies in systemic lupus erythematosusP Budde, H-D Zucht, S Vordenbäumen, et al.Rheumatology International|September 13, 2013
As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous goutA-K Tausche, M Christoph, M Forkmann, et al.Life Sciences|June 22, 1999
Janus kinases and their role in growth and diseaseM Aringer, A Cheng, J W Nelson, et al.Annals of the Rheumatic Diseases|April 1, 2008
Characterisation of cellular and humoral autoimmune responses to histone H1 and core histones in human systemic lupus erythaematosusG H Stummvoll, R D Fritsch, B Meyer, et al.British Journal of Rheumatology|February 4, 1998
Photopheresis treatment enhances CD95 (fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosisM Aringer, W B Graninger, J S Smolen, et al.Clinical and Experimental Immunology|April 18, 2003
Functional and molecular aspects of transient T cell unresponsiveness: role of selective interleukin-2 deficiencyM D Köller, H P Kiener, M Aringer, et al.Lupus|May 12, 2006
ICF core sets: how to specify impairment and function in systemic lupus erythematosusM Aringer, T A Stamm, D S Pisetsky, et al.Pageof 13